Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)

NCT03297294 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

142

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due to animal toxicity data

Conditions

Painful Diabetic Neuropathy

Interventions

DRUG: EMA401
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals